Evidence map›Paper›PMID 42707752›Full record

ArticleCureus2026

Ganglioside Antibodies as Formidable Neurologic Mimickers: A Case Report of Dual Anti-GQ1b and Asialo-GM1 Antibody Syndrome.

Emily Ahner, Khalid Haikal, Sannah Vasaya, Paul Janda, Aroucha Vickers

Abstract readCase Reports
In one paragraph

Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Emily AhnerMedicine, University of Nevada Las Vegas School of Medicine, Las Vegas, USA.
Khalid HaikalNeurology, Valley Hospital Medical Center, Las Vegas, USA.
Sannah VasayaNeurology, Valley Hospital Medical Center, Las Vegas, USA.
Paul JandaNeurology, Valley Hospital Medical Center, Las Vegas, USA.
Aroucha VickersNeurology, Las Vegas Neurology Center, Las Vegas, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The neurologic manifestations of anti-GQ1b antibody syndrome continue to expand and include a spectrum of immune-mediated neuropathies such as Miller Fisher syndrome, Bickerstaff brainstem encephalitis, and optic neuropathy. Asialo-GM1 antibodies are associated with motor or sensorimotor neuropathies, particularly multifocal motor neuropathy. Reports describing concurrent seropositivity for anti-GQ1b and asialo-GM1 antibodies presenting with unilateral facial weakness and limb symptoms remain scarce. A 55-year-old woman with chronic back pain initially presented to an outside facility with new-onset left lower motor neuron facial palsy accompanied by paresthesia and extremity weakness. Neuro-axis MRI demonstrated moderate-to-severe multilevel spinal and neuroforaminal stenosis. She was discharged with prednisone and acyclovir for presumed idiopathic Bell's palsy. Shortly thereafter, she presented to our institution with worsening symptoms. Examination revealed diminished strength, hypoesthesia, and decreased reflexes with a persistent left lower motor neuron cranial nerve VII palsy. The remainder of the cranial nerve examination was normal, and there was no ophthalmoplegia or ataxia. Lumbar puncture demonstrated albuminocytologic dissociation. A ganglioside antibody panel was positive for anti-GQ1b and asialo-GM1 antibodies.  This case highlights an unusual presentation of concurrent anti-GQ1b and asialo-GM1 antibody positivity manifesting as unilateral facial palsy and limb weakness initially attributed to Bell's Palsy. Recognition of ganglioside antibody syndromes as potential mimickers of Bell's palsy is essential to ensure prompt diagnosis and treatment, thereby reducing the risk of neurological morbidity.

Indexed as

albuminocytologic dissociationasialo-gm1 antibodiesfacial nerve palsyganglioside antibody neuropathyintravenous immunoglobulin (ivig)

Identifiers

PMID42707752
PMCPMC13549415

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.